Skip to content

No results found

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

VRAX Virax Biolabs Group Limited Ordinary Shares
$0.17 0.00% 0.00
Notify me if price changes either direction
Interactive Brokers Logotype

Buy VRAX stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 1.3M
Enterprise value -1999766
Trailing PE -0.10518518127041
Forward PE -0.725
PEG Ratio -0.725
Enterprise to EBITDA 0.36
Enterprise to revenue -669.714
Price to book MRQ 0.21428572
Price to sales TTM 432.5777

Financials

Fiscal Year Ends 2025-03-31
Most Recent Quarter (MRQ) 2025-09-30
Revenue (TTM) 2986
EBITDA -5556497
Diluted EPS TTM -1.22
Total Cash (MRQ) 3.4M
Current ratio (MRQ) 11.354
Operating Cash Flow (TTM) -5405240

VRAX trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent VRAX News

Home

No results found

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.